![Norbert Oppitz](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 4 M $ in data 31/05/2026
Norbert Oppitz is currently the Head-International at Swedish Orphan Biovitrum AB. Previously, he worked as the Head-Latin America at Nycomed AB.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 12/06/2026 | 86.954 ( 0,02% ) | 4 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Corporate Officer/Principal | 02/10/2017 |
| Società | Posizione | Fine |
|---|---|---|
Nycomed AB
 Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Corporate Officer/Principal | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 2 |
|---|---|
Nycomed AB
Nycomed AB Pharmaceuticals: MajorHealth Technology Provides medicines and products for hospitals, specialists and general practitioners | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
